ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 3 مورد
نسخه الکترونیک
medimedia.ir

Proposed diagnostic features of asthma and COPD overlap

Proposed diagnostic features of asthma and COPD overlap
Study Major criteria Minor criteria Diagnosis
Gibson, 2009[1]
  • Clinical symptoms of chronic airway disease, FEV1/FVC <70%
  • FEV1 <80%
  • Bronchial hyper-responsiveness defined as a PD15 <12 mL (provocative dose of hypertonic saline that induces a 15% fall in FEV1)
  3 major criteria
Soler-Cataluna, 2011[2] COPD plus:
  • Positive bronchodilator test defined by increase in FEV1 ≥15% and ≥400 mL
  • Sputum eosinophilia
  • History of asthma
COPD plus:
  • High total serum IgE
  • Personal history of atopy
  • Positive bronchodilator test, ie, increase in FEV1 ≥12% and ≥200 mL over baseline on ≥2 occasions

2 major criteria

OR

1 major criteria

AND

2 minor criteria
Koblizek, 2013[3] COPD plus:
  • Positive bronchodilator test defined by increase in FEV1 >15% and >400 mL
  • Methacholine challenge test positivity
  • FENO ≥45 to 50 ppb and/or sputum eosinophils >3%
  • History of asthma
COPD plus:
  • Mildly positive bronchodilator test, ie, increase in FEV1 >12% and >200 mL
  • Elevated IgE
  • History of atopy

2 major criteria

OR

1 major criteria

AND

2 minor criteria
GINA/GOLD Criteria, 2015[4] More likely COPD if:
  • Onset age >40 years
  • Persistence of symptoms
  • Daily symptoms with exertional dyspnea and good/bad days
  • Chronic cough and sputum precede onset of dyspnea, unrelated to triggers
  • Documented persistent airflow limitation (post-bronchodilator FEV1/FVC <70%)
  • Lung function abnormal between symptoms
  • Previous doctor diagnosis of COPD, chronic bronchitis or emphysema
  • Heavy exposure to a risk factor (tobacco smoke, biomass fuel)
  • Symptoms slowly worsening over time (progressive course over years)
  • Rapid-acting bronchodilator treatment provides only limited relief
  • Chest radiograph with features of severe hyperinflation
More likely asthma if:
  • Onset age <20 years
  • Variation in symptoms within short periods
  • Worsening of symptoms at night/early morning
  • Symptoms triggered by exercise, emotions/laughter, dust, or exposure to allergens
  • Documented airflow limitation variability (peak flow, spirometry)
  • Lung function normal between symptoms
  • Prior doctor diagnosis of asthma
  • Family history of asthma or atopy/eczema
  • No worsening of symptoms over time (symptoms vary either seasonally or from year to year)
  • May improve spontaneously or have an immediate response to bronchodilators or to inhaled steroids over weeks
  • Chest radiograph normal

If ≥3 items are present for either asthma or COPD, the patient is likely to have that disease

A similar number of items for asthma and COPD is suggestive for ACO
Cosio, 2016[5] COPD plus:
  • History of asthma
  • Bronchodilator response to salbutamol >15% and 400 mL
COPD plus:
  • IgE >100 IU
  • History of atopy
  • Two separated bronchodilator responses to salbutamol >12% and 200 mL
  • Blood eosinophils >5%

1 major criteria

OR

2 minor criteria
Sin, 2016[6] COPD plus:
  • FEV1/FVC <0.7 or LLN in patients ≥40 years of age
  • ≥10 pack years of tobacco smoking OR equivalent indoor or outdoor air pollution exposure
  • Documented history of asthma before 40 years of age OR bronchodilator reversibility >400 mL in FEV1
COPD plus:
  • Documented history of atopy or allergic rhinitis
  • Bronchodilator reversibility of FEV1 ≥200 mL and 12% from baseline on ≥2 visits
  • Peripheral blood eosinophil count of ≥300 cells/mL

3 major criteria

AND

1 minor criteria
Cataldo, 2017[7] ACO in a COPD patient:
  • High degree of variability in airway obstruction over time: FEV1 variation ≥400 mL
  • High degree of response to bronchodilators: >200 mL and 12% above baseline
ACO in a COPD patient:
  • Personal or family history of atopy and/or IgE sensitivity to one or more airborne allergens
  • Elevated blood or sputum eosinophils or increased FENO
  • Asthma diagnosed before the age of 40
  • Symptom variability
  • Age (in favor of asthma)

2 major criteria

AND

1 minor criteria
ACO in an asthma patient:
  • Persistence over time of airflow obstruction (FEV1/FVC <0.7 or <LLN)
  • Exposure to noxious particles or gases, with ≥10 pack years for smokers
ACO in an asthma patient:
  • Lack of response on acute bronchodilator tests
  • Reduced lung diffusion capacity
  • Little variability in airway obstruction
  • Age in favor of COPD (>40 years)
  • Presence of emphysema on chest CT scan
Miravittles, 2017[8]
  • Age >35 years
  • Postbronchodilator FEV1/FVC <70%
  • ≥10 pack years tobacco smoke
  • Current diagnosis of asthma
  • No current diagnosis of asthma but a bronchodilator response to albuterol ≥15% and 400 mL and/or blood eosinophils ≥300 cells/microL

3 major criteria

AND

1 minor criteria
FEV1: forced expiratory volume in one second; FVC: forced vital capacity; PD15: provocative dose; COPD: chronic obstructive pulmonary disease; IgE: immunoglobulin E; FENO: fraction of exhaled nitric oxide; ppb: parts per billion; ACO: asthma COPD overlap; IU: international units; LLN: lower limit of normal.
References:
  1. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64:728.
  2. Soler-Cataluna JJ, Cosio B, Izquierdo JL, et al. Consensus document on the overlap phenotype COPD-asthma in COPD. Arch Bronconeumol 2012; 48:331.
  3. Koblizek V, Chlumsky J, Zindr V, et al. Chronic Obstructive Pulmonary Disease: official diagnosis and treatment guidelines of the Czech Pneumological and Phthisiological Society; a novel phenotypic approach to COPD with patient-oriented care. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2013; 157:189.
  4. goldcopd.org/wp-content/uploads/2016/04/GOLD_ACOS_2015.pdf (Accessed on October 16, 2019).
  5. Cosio BG, Soriano JB, Lopez-Campos JL, et al. Defining the Asthma-COPD Overlap Syndrome in a COPD Cohort. Chest 2016; 149:45.
  6. Sin DD, Miravitlles M, Mannino DM, et al. What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion. Eur Respir J 2016; 48:664.
  7. Cataldo D, Corhay JL, Derom E, et al. A Belgian survey on the diagnosis of asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis 2017; 12:601.
  8. Miravitlles M, Alvarez-Gutierrez FJ, Calle M, et al. Algorithm for identification of asthma-COPD overlap: consensus between the Spanish COPD and asthma guidelines. Eur Respir J 2017; 49.
Graphic 126333 Version 1.0

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟